EcoDrugPlus

Ensembl ID : ENSMOCG00000011949
Gene Symbol: -
Cross references: -
60 Possible Orthologues:

Ensembl ID : ENSMOCG00000017884
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Ensembl ID : ENSMOCG00000017801
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSMOCG00000018588
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSMOCG00000012304
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSMOCG00000012949
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSMOCG00000012368
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSMOCG00000007676
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSMOCG00000002924
Gene Symbol: -
Cross references: -
122 Possible Orthologues:

Ensembl ID : ENSMOCG00000007073
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSMOCG00000019870
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSMOCG00000004072
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).